2092 A Rare Case of Primary Colonic Lymphoma Mimicking Metastatic Adenocarcinoma in a Patient With Ulcerative Colitis

2019 ◽  
Vol 114 (1) ◽  
pp. S1167-S1167
Author(s):  
Meher S. Mavuram ◽  
Smita Maruvada ◽  
Shazia Rashid ◽  
Nazar Hafiz ◽  
Catherine Chaudoir ◽  
...  
Author(s):  
Chhagan Lal Birda ◽  
Ashish Agarwal ◽  
Amit Goyal

2019 ◽  
Vol 114 (1) ◽  
pp. S726-S726
Author(s):  
Shiva Vangimalla ◽  
Muhammad U. Mirza ◽  
Tandy Agostini ◽  
Mitesh R. Patel

2019 ◽  
Vol 114 (1) ◽  
pp. S1159-S1159
Author(s):  
Jamil O. Alexis ◽  
He Qiu ◽  
Janice G. Shen ◽  
Keith Sultan
Keyword(s):  

2014 ◽  
Vol 7 (1) ◽  
pp. 16-17
Author(s):  
MM Rashid ◽  
H Rabbi ◽  
MA Islam ◽  
MM Husain ◽  
AR Minn ◽  
...  

Pancreatolithiasis is a risk factor for developing pancreatic cancer. We report here a rare case of sarcomatoid carcinoma of the pancreas in a 55-year old diabetic male associated with pancreatolithiasis. CT scan of abdomen revealed a large operable mass occupying the distal body and tail of the pancreas. Per-operative survey revealed a small metastatic nodule in the surface of hepatic segment IVa. Histopathology of the distal pancreatic lesion revealed sarcomatoid carcinoma. Hepatic nodule was a metastatic adenocarcinoma. Distal pancreatectomy and splenectomy was done en-mass, along with non-anatomical resection of the hepatic metastatic nodule. Combined with six cycles of chemotherapy, the patient survived a total of another fourteen months. DOI: http://dx.doi.org/10.3329/imcj.v7i1.17742 Ibrahim Med. Coll. J. 2013; 7(1): 12-15


2013 ◽  
Vol 12 (5) ◽  
pp. 615
Author(s):  
Mohsen Meidani ◽  
Kiana Shirani ◽  
Majid Rezvani ◽  
Parvin Mahzouni

2018 ◽  
Vol 10 (2) ◽  
pp. 145-148 ◽  
Author(s):  
Sebastian Hoffmann ◽  
Mark Berneburg ◽  
Stephan Schreml

Bullous pemphigoid (BP) is a blistering autoimmune disease mainly observed in elderly patients. Several triggers are known for this autoimmune disease and some drugs are known to be a cause of BP. However, there are only few case reports on the induction of BP under adalimumab therapy. Other autoimmune diseases, such as lupus erythematosus, are also known to occur under TNF inhibition. Here, we report on an 81-year-old patient who received adalimumab for ulcerative colitis and subsequently developed BP. Other causes of BP (tumors, other drugs, viral or toxoplasma infections) were excluded. We initiated a topical and systemic therapy (prednisolone 1 mg/kg/day) and stopped the adalimumab injections. The patient’s symptoms resolved quickly and we were able to taper corticosteroid therapy. This rare case highlights the importance to monitor for autoimmune events during TNF inhibition.


2012 ◽  
Vol 24 ◽  
pp. 56-62
Author(s):  
Ashalata Ganepalli ◽  
Bhargavi Krishna Ayinampudi ◽  
Venkat Baghirath Pacha ◽  
Sanjay Reddy Podduturi ◽  
Shailaja Gangula ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document